{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:51:05Z","timestamp":1790869865874,"version":"4.1.0"},"reference-count":9,"publisher":"American Psychiatric Association Publishing","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PS"],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.1176\/appi.ps.20250646","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:00:15Z","timestamp":1785384015000},"page":"977-980","source":"Crossref","is-referenced-by-count":1,"title":["Public Support for State Laws Requiring Addiction Programs to Offer FDA-Approved Medications for Opioid Use Disorder"],"prefix":"10.1176","volume":"77","author":[{"given":"Colleen L.","family":"Barry","sequence":"first","affiliation":[{"name":"Cornell Jeb E. Brooks School of Public Policy, Cornell University, Ithaca, NY."},{"name":"Division of Health Policy and Economics, Weill Cornell Medical College, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gutkind","sequence":"additional","affiliation":[{"name":"Division of Health Policy and Economics, Weill Cornell Medical College, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Niederdeppe","sequence":"additional","affiliation":[{"name":"Cornell Jeb E. Brooks School of Public Policy, Cornell University, Ithaca, NY."},{"name":"Department of Communication, Cornell University, Ithaca, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Franklin","family":"Fowler","sequence":"additional","affiliation":[{"name":"Department of Government, Wesleyan University, Middletown, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma E.","family":"McGinty","sequence":"additional","affiliation":[{"name":"Division of Health Policy and Economics, Weill Cornell Medical College, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"e_1_3_2_2_2","unstructured":"US Overdose Deaths Decrease Almost 27% in 2024. Atlanta Centers for Disease Control and Prevention 2025. https:\/\/www.cdc.gov\/nchs\/pressroom\/releases\/20250514.html"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.27488"},{"key":"e_1_3_2_4_2","volume-title":"Medications for Opioid Use Disorder Save Lives","author":"National Academies of Sciences, Engineering, and Medicine","year":"2019","unstructured":"National Academies of Sciences, Engineering, and Medicine: Medications for Opioid Use Disorder Save Lives. Washington, DC, National Academies Press, 2019. https:\/\/www.nationalacademies.org\/projects\/HMD-HSP-18-14\/publication\/25310"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103786"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.11913"},{"key":"e_1_3_2_7_2","volume-title":"42 CFR Part 8 Final Rule: Frequently Asked Questions","year":"2026","unstructured":"42 CFR Part 8 Final Rule: Frequently Asked Questions. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2026. https:\/\/www.samhsa.gov\/substance-use\/treatment\/opioid-treatment-program\/42-cfr-part-8\/faqs"},{"key":"e_1_3_2_8_2","volume-title":"New Federal Rules Cannot Improve Methadone Delivery Without State Actions","author":"McGaffey F","year":"2024","unstructured":"McGaffey F: New Federal Rules Cannot Improve Methadone Delivery Without State Actions. Philadelphia, Pew Charitable Trusts, 2024. https:\/\/www.pew.org\/en\/research-and-analysis\/articles\/2024\/02\/21\/new-federal-rules-cannot-improve-methadone-delivery-without-state-actions"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2023.01306"},{"key":"e_1_3_2_10_2","volume-title":"Stata Statistical Software: Release 17","year":"2021","unstructured":"Stata Statistical Software: Release 17. College Station, TX, StataCorp, 2021"}],"container-title":["Psychiatric Services"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:01:37Z","timestamp":1790827297000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ps.20250646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"alternative-id":["10.1176\/appi.ps.20250646"],"URL":"https:\/\/doi.org\/10.1176\/appi.ps.20250646","relation":{},"ISSN":["1075-2730","1557-9700"],"issn-type":[{"value":"1075-2730","type":"print"},{"value":"1557-9700","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}